“Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

(2010) Deborah L. Hoffman et al.   PAIN

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

(2010) Andrew R. Moore et al.   PAIN

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

(2009) R A Moore et al.   ANNALS OF THE RHEUMATIC DISEASES

The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders

(2009) John T. Farrar et al.   JOURNAL OF PAIN

Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

(2009) M. K. KVAMME et al.   JOURNAL OF RHEUMATOLOGY

Patient-Centered Perspective on Treatment Outcomes in Chronic Pain

(2009) Erin M. O'Brien et al.   PAIN MEDICINE

Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

(2008) Sebastian Straube et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain

(2008) Henry J. McQuay et al.   PAIN

Placebo response in neuropathic pain trials☆

(2008) Steve N. Quessy et al.   PAIN